Progenics (PGNX) delivered earnings and revenue surprises of 18.52% and -20.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? Zacks Progenics: 4Q Earnings Snapshot - ExpressNews.com Mar 13, 2020 · NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Friday reported a loss of $11.3 million in its fourth quarter. The New York-based company said … PGNX Progenics Pharmaceuticals, Inc. Stock Quote Progenics Pharmaceuticals, Inc., an oncology company, develops, manufactures, and commercializes pharmaceutical products and other technologies to target, diagnose, and treat cancer in the United States and internationally.
IB does not accept short sale orders for US stocks that are not eligible for DTC CZA, USD, INVESCO ZACKS MID-CAP ETF, Log In to Check Availability PGNX , USD, PROGENICS PHARMACEUTICALS, Log In to Check Availability.
PGNX: Progenics Pharmaceuticals Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Progenics Pharmaceuticals Inc. from Zacks Investment Research PGNX: Progenics Pharmaceuticals Inc. - Price & EPS ... PGNX: Progenics Pharmaceuticals Inc. price and EPS surprise. Get the latest price and EPS surprise information from Zacks Investment Research. PGNX Stock Price, Forecast & News (Progenics Pharmaceuticals)
Nov 05, 2019 · Their average twelve-month price target is $12.00, suggesting that the stock has a possible upside of 300.00%. The high price target for PGNX is $14.00 and the low price target for PGNX is $10.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
You can filter news items, SEC filings and tweets by the stock symbols of the active deals, that you are interested in, Progenics Pharmaceuticals, Inc. (PGNX ). PGNX - Zacks Investment Research View Progenics Pharmaceuticals Inc. PGNX investment & stock information. Get the latest Progenics Pharmaceuticals Inc. PGNX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. All News for PGNX - Zacks Investment Research
Analyzing Progenics Pharmaceuticals (NASDAQ:PGNX) stock? View PGNX's stock price, price target, earnings, financials, forecast, insider trades, news, and
Progenics: 4Q Earnings Snapshot Mar 13, 2020 · NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Friday reported a loss of $11.3 million in its fourth quarter. The New York-based company said it had a loss of 13 cents per share. The biopharmaceutical company posted revenue of $15.1 … Progenics Pharmaceuticals (PGNX) in Focus: Stock Gains 8.3% Feb 28, 2017 · Progenics Pharmaceuticals PGNX was a big mover last session, as the company saw its shares rise above 8% on the day. The move came on solid … Analysts Estimate Progenics (PGNX) to Report a Decline in ... On the other hand, the stock currently carries a Zacks Rank of #3. Progenics Pharmaceuticals Inc. (PGNX): Free Stock Analysis Report To read this article on Zacks.com click here. PGNX Stock Quote of Progenics Pharmaceuticals
Progenics Pharmaceuticals (NASDAQ:PGNX) Raised to “Buy” at ...
7:46am. Implied Volatility Surging for Verastem (VSTM) Stock Options - www. zacks.com $AMGN $GILD $MRK $PFE $PGNX $VSTM Tax Reform Will Impact NYSE:BHS / Bausch Health Companies - Stock Price Quote and News ( GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced financial results for the fourth quarter and full-year 2019. 12-13 zacks.com 6 Jan 2020 Type of Stock. Small- 312-265-9588 / firstname.lastname@example.org PGNX. Progenics Pharmaceuticals. £4.85. £419. £411 Oncology, small Vanda Pharmaceuticals (VNDA) Catches Eye: Stock Jumps 8.7%. Zacks 557d. ADIL On Track, PGNX Slumps On Phase III Study Failure, VNDA On Watch. IB does not accept short sale orders for US stocks that are not eligible for DTC CZA, USD, INVESCO ZACKS MID-CAP ETF, Log In to Check Availability PGNX , USD, PROGENICS PHARMACEUTICALS, Log In to Check Availability.
Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock quote, history, news and other vital information to help you with your stock trading and investing. Brokerage Recommendations - Zacks Investment Research PGNX: Progenics Pharmaceuticals Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Progenics Pharmaceuticals Inc. Common Stock (PGNX ...